Russell K. Soon, Jim S. Yan, James P. Grenert, Jacquelyn J. Maher 

Slides:



Advertisements
Similar presentations
Volume 60, Issue 5, Pages (May 2014)
Advertisements

REV-ERBα Activates C/EBP Homologous Protein to Control Small Heterodimer Partner–Mediated Oscillation of Alcoholic Fatty Liver  Zhihong Yang, Hiroyuki.
Volume 127, Issue 6, Pages (December 2004)
Volume 149, Issue 2, Pages e10 (August 2015)
Volume 139, Issue 1, Pages e7 (July 2010)
Volume 133, Issue 2, Pages (August 2007)
Volume 146, Issue 2, Pages e3 (February 2014)
Volume 132, Issue 5, Pages (May 2007)
Won Hee Choi, Jiyun Ahn, Chang Hwa Jung, Jung Sook Seo, Tae Youl Ha 
Volume 146, Issue 2, Pages e7 (February 2014)
Volume 131, Issue 1, Pages (July 2006)
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice
Volume 57, Issue 5, Pages (November 2012)
Won Hee Choi, Jiyun Ahn, Chang Hwa Jung, Jung Sook Seo, Tae Youl Ha 
Volume 8, Issue 4, Pages (October 2008)
Omega 3 – Omega 6: What is right for the liver?
Aryl Hydrocarbon Receptor Regulates Pancreatic IL-22 Production and Protects Mice From Acute Pancreatitis  Jing Xue, David T.C. Nguyen, Aida Habtezion 
Volume 135, Issue 6, Pages (December 2008)
Volume 137, Issue 6, Pages e2 (December 2009)
SREBP-1 pathway is involved in MPST-regulated fat accumulation in hepatocytes. SREBP-1 pathway is involved in MPST-regulated fat accumulation in hepatocytes.
Volume 138, Issue 7, Pages e7 (June 2010)
Volume 64, Issue 1, Pages (January 2016)
Volume 137, Issue 4, Pages e5 (October 2009)
UV Modulation of Subcutaneous Fat Metabolism
Volume 134, Issue 2, Pages (February 2008)
Volume 79, Issue 8, Pages (April 2011)
Volume 143, Issue 3, Pages (September 2012)
Volume 144, Issue 5, Pages e6 (May 2013)
Volume 129, Issue 5, Pages (November 2005)
Volume 141, Issue 4, Pages e5 (October 2011)
Volume 138, Issue 2, Pages e2 (February 2010)
Volume 127, Issue 6, Pages (December 2004)
Volume 147, Issue 4, Pages (October 2014)
Volume 138, Issue 2, Pages e1 (February 2010)
Volume 132, Issue 1, Pages (January 2007)
Volume 136, Issue 4, Pages (April 2009)
Volume 7, Issue 3, Pages (March 2008)
Volume 135, Issue 6, Pages e7 (December 2008)
Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity  Zhang-Xu Liu, Sugantha Govindarajan,
Volume 138, Issue 7, Pages e3 (June 2010)
This Month in Gastroenterology
Volume 61, Issue 6, Pages (December 2014)
Volume 134, Issue 4, Pages (April 2008)
Volume 134, Issue 7, Pages e3 (June 2008)
Volume 132, Issue 5, Pages (May 2007)
Volume 139, Issue 2, Pages e1 (August 2010)
Volume 126, Issue 3, Pages (March 2004)
Jinhan He, Shigeru Nishida, Meishu Xu, Makoto Makishima, Wen Xie 
Volume 132, Issue 3, Pages (March 2007)
Volume 134, Issue 2, Pages (February 2008)
Figure 2 Lipid metabolism and metabolism-disrupting chemicals.
Volume 135, Issue 4, Pages (October 2008)
Volume 137, Issue 4, Pages (October 2009)
Volume 136, Issue 6, Pages (March 2009)
Volume 16, Issue 4, Pages (July 2016)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 10, Issue 5, Pages (November 2009)
Jieun Lee, Joseph Choi, Susanna Scafidi, Michael J. Wolfgang 
Volume 6, Issue 1, Pages (July 2007)
Volume 144, Issue 5, Pages e4 (May 2013)
Volume 61, Issue 6, Pages (December 2014)
Prevention of Steatosis by Hepatic JNK1
Volume 8, Issue 5, Pages (November 2008)
Volume 15, Issue 2, Pages (April 2016)
Covering the Cover Gastroenterology
Knockdown of MPST weakens JNK phosphorylation, ameliorates hepatic oxidative stress and suppresses the release of MCP-1. Knockdown of MPST weakens JNK.
Trunk Fat as a Determinant of Liver Disease
Volume 44, Issue 2, Pages (February 2006)
Volume 137, Issue 6, Pages e2 (December 2009)
The GCN2 eIF2α Kinase Regulates Fatty-Acid Homeostasis in the Liver during Deprivation of an Essential Amino Acid  Feifan Guo, Douglas R. Cavener  Cell.
Presentation transcript:

Stress Signaling in the Methionine-Choline–Deficient Model of Murine Fatty Liver Disease  Russell K. Soon, Jim S. Yan, James P. Grenert, Jacquelyn J. Maher  Gastroenterology  Volume 139, Issue 5, Pages 1730-1739.e1 (November 2010) DOI: 10.1053/j.gastro.2010.07.046 Copyright © 2010 AGA Institute Terms and Conditions

Figure 1 Time course of steatosis and steatohepatitis in MCD-fed mice. (A) Mice were fed control (MCS) or MCD diets for 4–21 days. Liver sections were stained with H&E. (B) ALT was quantitated in the serum of mice fed MCS or MCD formulas (n = 5) for 4–21 days. *P < .05 vs MCS. Gastroenterology 2010 139, 1730-1739.e1DOI: (10.1053/j.gastro.2010.07.046) Copyright © 2010 AGA Institute Terms and Conditions

Figure 2 IRE1 activation and expression of downstream targets in MCD-fed mice. (A) IRE1 activation and XBP-1s expression were assessed by immunoblotting in liver homogenates from mice fed MCS (−) or MCD (+) formulas for 4–21 days. (B) IRE1 activation was compared in liver homogenates from mice fed chow, MCS, or MCD formulas for 21 days. (C) RNA was extracted from the livers of mice fed chow, MCS, or MCD diets for 21 days. mRNA encoding XBP-1 and target genes Edem1, Erdj4, and Dnajc3 was measured by quantitative polymerase chain reaction (n = 5). *P < .05 vs chow. Gastroenterology 2010 139, 1730-1739.e1DOI: (10.1053/j.gastro.2010.07.046) Copyright © 2010 AGA Institute Terms and Conditions

Figure 3 Effect of MCD feeding on JNK, caspase-12, and ATF6 signaling in liver. (A) Liver homogenates were prepared from mice fed MCS (−) or MCD (+) diets for 4–21 days. JNK activation, cJun induction, and procaspase-12 cleavage were assessed by Western blotting. (B) mRNA encoding 3 ATF6 target genes was measured by quantitative polymerase chain reaction in the livers of mice fed chow, MCS, or MCD formulas for 21 days (n = 5). Gastroenterology 2010 139, 1730-1739.e1DOI: (10.1053/j.gastro.2010.07.046) Copyright © 2010 AGA Institute Terms and Conditions

Figure 4 Effect of MCD feeding on molecules involved in the ISR. (A) The phosphorylation of PERK and GCN2 was monitored in the livers of mice fed MCS (−) or MCD (+) diets for 4–21 days. Thapsigargin treatment (TG) was used as a positive control. The activation of eIF2α and expression of CHOP also were monitored over the 21-day interval by Western blotting. (B) mRNA encoding CHOP and its downstream targets TRB3, ERO1, and Bcl-xL were measured by quantitative polymerase chain reaction in the livers of mice fed MCS or MCD formulas for 21 days (n = 5). (C) mRNA encoding several lipogenic genes was measured by quantitative polymerase chain reaction in the livers of mice fed MCS or MCD formulas for 21 days (n = 5). *P < .05 vs MCS. Gastroenterology 2010 139, 1730-1739.e1DOI: (10.1053/j.gastro.2010.07.046) Copyright © 2010 AGA Institute Terms and Conditions

Figure 5 Impact of clofibrate treatment on stress signaling in MCD-fed mice. (A) Mice were fed MCS or MCD formulas with or without 0.5% (wt/wt) clofibrate for 14 days. Liver sections were stained with H&E. (B) Stress signaling was assessed by Western blotting in the livers of mice fed MCS and MCD formulas with or without clofibrate for 14 days. (C) The hepatic triglyceride content of mice fed diets with or without clofibrate was assayed as outlined in the Materials and Methods section. Biochemical and histologic parameters of liver injury also were measured at 14 days (n = 10). *P < .05 for MCD vs MCS. ‡P < .05 for MCD vs MCD + clofibrate. Gastroenterology 2010 139, 1730-1739.e1DOI: (10.1053/j.gastro.2010.07.046) Copyright © 2010 AGA Institute Terms and Conditions

Figure 6 Influence of CHOP on the development of MCD-mediated liver disease. (A) CHOP mRNA expression was measured by quantitative polymerase chain reaction in the livers of wild-type (CHOP+/+) and CHOP-deficient (CHOP−/−) mice after 21 days of MCS or MCD feeding (n = 8). (B) Liver histology in wild-type and CHOP−/− mice was assessed after 21 days of MCD feeding. Top panels show H&E stains; bottom panels illustrate TUNEL stains. TUNEL–positive cells are marked with arrowheads. (C) Hepatic triglyceride content, serum ALT levels, and histologic features of liver injury were measured in CHOP+/+ and CHOP−/− mice fed MCD formulas for 21 days (n = 8). (D) The expression of CHOP, C/EBPα, and C/EBPβ was measured by Western blotting in the livers of CHOP+/+ and CHOP−/− mice after 21 days of MCD feeding. (E) The expression of stress signaling molecules in CHOP−/− mice was assessed by Western blotting after 21 days of MCD feeding and expressed as a relative value in comparison with CHOP+/+ controls treated in the same fashion (n = 5). *P < .05 vs CHOP+/+. Gastroenterology 2010 139, 1730-1739.e1DOI: (10.1053/j.gastro.2010.07.046) Copyright © 2010 AGA Institute Terms and Conditions

Supplementary Figure 1 Hepatic expression of oxidative and lipogenic genes in mice fed formulas with or without clofibrate. Mice were fed MCS or MCD formulas with or without clofibrate for 21 days. mRNA encoding a panel of genes involved in lipid metabolism was measured by quantitative polymerase chain reaction. VLCAD, very-long-chain acyl dehydrogenase; SCAD, short-chain acyl dehydrogenase; BIFUNC PROT, bifunctional protein; ACOX, acyl CoA oxidase; SREBP1, sterol regulatory element binding protein-1; ACC1, acetyl CoA carboxylase-1; ACLY, adenosine triphosphate citrate lyase; FAS, fatty acid synthase; SCD1, stearoyl CoA desaturase-1; GPAT, glycerol-3-phosphate acyltransferase; DGAT1, diacylglycerol acyltransferase-1; DGAT2, diacylglycerol acyltransferase-2. Gastroenterology 2010 139, 1730-1739.e1DOI: (10.1053/j.gastro.2010.07.046) Copyright © 2010 AGA Institute Terms and Conditions

Supplementary Figure 2 Hepatic gene expression in wild-type and CHOP-deficient mice after 21 days of MCD feeding. CHOP+/+ and CHOP−/− mice were fed MCD formulas for 21 days. mRNA encoding a panel of stress-related, metabolic, and inflammatory genes was measured by quantitative polymerase chain reaction. Gastroenterology 2010 139, 1730-1739.e1DOI: (10.1053/j.gastro.2010.07.046) Copyright © 2010 AGA Institute Terms and Conditions